XML 25 R12.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS' EQUITY
3 Months Ended
Apr. 30, 2023
Equity [Abstract]  
Stockholders' Equity STOCKHOLDERS' EQUITY
Stock Rollforward
The following table presents a reconciliation of the number of shares of our common stock outstanding and cash dividends per share:
shares in millionsThree Months Ended
April 30,
2023
May 1,
2022
Common stock:
Shares at beginning of period
1,794 1,792 
Shares issued under employee stock plans, net
Shares at end of period
1,795 1,793 
Treasury stock:
Shares at beginning of period
(778)(757)
Repurchases of common stock(10)(7)
Shares at end of period
(788)(764)
Shares outstanding at end of period1,007 1,029 
Cash dividends per share$2.09 $1.90 
Share Repurchases
In August 2022, our Board of Directors approved a $15.0 billion share repurchase authorization that replaced the previous authorization of $20.0 billion, which was approved in May 2021. The August 2022 authorization does not have a prescribed expiration date. As of April 30, 2023, $9.5 billion of the $15.0 billion share repurchase authorization remained available.
The following table presents information about our repurchases of common stock, all of which were completed through open market purchases:
in millionsThree Months Ended
April 30,
2023
May 1,
2022
Total number of shares repurchased10 
Total cost of shares repurchased (1)
$3,028 $2,250 
—————
(1) Effective January 1, 2023, the Company’s share repurchases are subject to a 1% excise tax as a result of the Inflation Reduction Act of 2022. Excise taxes incurred on share repurchases represent direct costs of the repurchase and are recorded as a part of the cost basis of the shares within treasury stock.
The cost of shares repurchased may differ from the repurchases of common stock amounts in the consolidated statements of cash flows due to unsettled share repurchases at the end of a period and excise taxes incurred on share repurchases.